FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296831547> ?p ?o ?g. }

• W4296831547 abstract "Background Despite patients with severe coronavirus disease (COVID-19) receiving standard triple therapy, including steroids, antiviral agents, and anticytokine therapy, health condition of certain patients continue to deteriorate. In Taiwan, the COVID-19 mortality has been high since the emergence of previous variants of this disease (such as alpha, beta, or delta). We aimed to evaluate whether adjunctive infusion of human umbilical cord mesenchymal stem cells (MSCs) (hUC-MSCs) on top of dexamethasone, remdesivir, and tocilizumab improves pulmonary oxygenation and suppresses inflammatory cytokines in patients with severe COVID-19. Methods Hospitalized patients with severe or critical COVID-19 pneumonia under standard triple therapy were separated into adjuvant hUC-MSC and non-hUC-MSC groups to compare the changes in the arterial partial pressure of oxygen (PaO 2 )/fraction of inspired oxygen (FiO 2 ) ratio and biological variables. Results Four out of eight patients with severe or critical COVID-19 received either one ( n = 2) or two ( n = 2) doses of intravenous infusions of hUC-MSCs using a uniform cell dose of 1.0 × 10 8 . Both high-sensitivity C-reactive protein (hs-CRP) level and monocyte distribution width (MDW) were significantly reduced, with a reduction in the levels of interleukin (IL)-6, IL-13, IL-12p70 and vascular endothelial growth factor following hUC-MSC transplantation. The PaO 2 /FiO 2 ratio increased from 83.68 (64.34–126.75) to 227.50 (185.25–237.50) and then 349.56 (293.03–367.92) within 7 days after hUC-MSC infusion ( P &lt; 0.001), while the change of PaO 2 /FiO 2 ratio was insignificant in non-hUC-MSC patients (admission day: 165.00 [102.50–237.61]; day 3: 100.00 [72.00–232.68]; day 7: 250.00 [71.00–251.43], P = 0.923). Conclusion Transplantation of hUC-MSCs as adjunctive therapy improves pulmonary oxygenation in patients with severe or critical COVID-19. The beneficial effects of hUC-MSCs were presumably mediated by the mitigation of inflammatory cytokines, characterized by the reduction in both hs-CRP and MDW." @default.
• W4296831547 created "2022-09-24" @default.
• W4296831547 creator A5005207939 @default.
• W4296831547 creator A5017562662 @default.
• W4296831547 creator A5024784197 @default.
• W4296831547 creator A5025368522 @default.
• W4296831547 creator A5033556892 @default.
• W4296831547 creator A5036955110 @default.
• W4296831547 creator A5038767250 @default.
• W4296831547 creator A5048978489 @default.
• W4296831547 creator A5049640991 @default.
• W4296831547 creator A5051246420 @default.
• W4296831547 creator A5053345367 @default.
• W4296831547 creator A5063466669 @default.
• W4296831547 creator A5069490714 @default.
• W4296831547 creator A5071457613 @default.
• W4296831547 creator A5077249337 @default.
• W4296831547 creator A5087686513 @default.
• W4296831547 creator A5088359420 @default.
• W4296831547 date "2022-09-23" @default.
• W4296831547 modified "2023-10-18" @default.
• W4296831547 title "Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia" @default.
• W4296831547 cites W1866257816 @default.
• W4296831547 cites W1997991819 @default.
• W4296831547 cites W2009626854 @default.
• W4296831547 cites W2021916724 @default.
• W4296831547 cites W2033075194 @default.
• W4296831547 cites W2035040282 @default.
• W4296831547 cites W2094024512 @default.
• W4296831547 cites W2168750058 @default.
• W4296831547 cites W2238141562 @default.
• W4296831547 cites W2337861353 @default.
• W4296831547 cites W2594734700 @default.
• W4296831547 cites W2603921207 @default.
• W4296831547 cites W2805892376 @default.
• W4296831547 cites W2921393982 @default.
• W4296831547 cites W3001118548 @default.
• W4296831547 cites W3007814559 @default.
• W4296831547 cites W3008028633 @default.
• W4296831547 cites W3010338568 @default.
• W4296831547 cites W3011102168 @default.
• W4296831547 cites W3011568661 @default.
• W4296831547 cites W3012421327 @default.
• W4296831547 cites W3012978473 @default.
• W4296831547 cites W3023674326 @default.
• W4296831547 cites W3030326137 @default.
• W4296831547 cites W3033975904 @default.
• W4296831547 cites W3036975780 @default.
• W4296831547 cites W3039648137 @default.
• W4296831547 cites W3039812894 @default.
• W4296831547 cites W3046680669 @default.
• W4296831547 cites W3046831413 @default.
• W4296831547 cites W3049660296 @default.
• W4296831547 cites W3078961638 @default.
• W4296831547 cites W3082102108 @default.
• W4296831547 cites W3120463228 @default.
• W4296831547 cites W3123599371 @default.
• W4296831547 cites W3127370607 @default.
• W4296831547 cites W3128359529 @default.
• W4296831547 cites W3130964932 @default.
• W4296831547 cites W3134757124 @default.
• W4296831547 cites W3139575126 @default.
• W4296831547 cites W3163979255 @default.
• W4296831547 cites W3165494388 @default.
• W4296831547 cites W3168415043 @default.
• W4296831547 cites W3175274971 @default.
• W4296831547 cites W3175449766 @default.
• W4296831547 cites W3180764364 @default.
• W4296831547 cites W3198593250 @default.
• W4296831547 cites W3204204885 @default.
• W4296831547 cites W3210397248 @default.
• W4296831547 cites W3210493238 @default.
• W4296831547 cites W4223898721 @default.
• W4296831547 doi "https://doi.org/10.3389/fmed.2022.1001979" @default.
• W4296831547 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36213639" @default.
• W4296831547 hasPublicationYear "2022" @default.
• W4296831547 type Work @default.
• W4296831547 citedByCount "1" @default.
• W4296831547 countsByYear W42968315472023 @default.
• W4296831547 crossrefType "journal-article" @default.
• W4296831547 hasAuthorship W4296831547A5005207939 @default.
• W4296831547 hasAuthorship W4296831547A5017562662 @default.
• W4296831547 hasAuthorship W4296831547A5024784197 @default.
• W4296831547 hasAuthorship W4296831547A5025368522 @default.
• W4296831547 hasAuthorship W4296831547A5033556892 @default.
• W4296831547 hasAuthorship W4296831547A5036955110 @default.
• W4296831547 hasAuthorship W4296831547A5038767250 @default.
• W4296831547 hasAuthorship W4296831547A5048978489 @default.
• W4296831547 hasAuthorship W4296831547A5049640991 @default.
• W4296831547 hasAuthorship W4296831547A5051246420 @default.
• W4296831547 hasAuthorship W4296831547A5053345367 @default.
• W4296831547 hasAuthorship W4296831547A5063466669 @default.
• W4296831547 hasAuthorship W4296831547A5069490714 @default.
• W4296831547 hasAuthorship W4296831547A5071457613 @default.
• W4296831547 hasAuthorship W4296831547A5077249337 @default.
• W4296831547 hasAuthorship W4296831547A5087686513 @default.
• W4296831547 hasAuthorship W4296831547A5088359420 @default.
• W4296831547 hasBestOaLocation W42968315471 @default.
• W4296831547 hasConcept C11988809 @default.
• W4296831547 hasConcept C126322002 @default.

• next